| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Howard G et al. | The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation factors VII and X. | 1977 | Br J Obstet Gynaecol | pmid:889752 |
| Speroff L et al. | The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. | 1996 | JAMA | pmid:8892714 |
| Istre O et al. | Hormone replacement therapy after transcervical resection of the endometrium. | 1996 | Obstet Gynecol | pmid:8885910 |
| Hill PV | Tubal pregnancy despite oral contraception. | 1977 | S. Afr. Med. J. | pmid:888044 |
| Farish E et al. | Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions. | 1996 | Atherosclerosis | pmid:8879436 |
| Stadberg E et al. | 17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. | 1996 | Maturitas | pmid:8861084 |
| Taskinen MR et al. | Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens. | 1996 | Arterioscler. Thromb. Vasc. Biol. | pmid:8857916 |
| Friedrich E | [The effect of low dose gestagens on the hypothalamic-pituitary-ovarian axis]. | 1977 | Fortschr. Med. | pmid:885464 |
| Pasapera AM et al. | In vitro molecular assessment of the mechanisms of action of 19-nor progestins used as contragestational agents. | 1995 | Arch. Med. Res. | pmid:8845651 |
| Görög S et al. | Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices. | 1995 | J Pharm Biomed Anal | pmid:8833970 |
| Brügmann E et al. | [Liver function studies under the influence of hormonal contraceptives (sequential preparations)]. | 1979 | Dtsch Z Verdau Stoffwechselkr | pmid:88322 |
| Valette A et al. | Norethindrone stimulates in vivo glycosyltransferases in the rat liver. | 1996 | Horm. Metab. Res. | pmid:8820994 |
| Görög S et al. | Analysis of steroids Part 50. Derivatization of ketosteroids for their separation and determination by capillary electrophoresis. | 1996 | J Pharm Biomed Anal | pmid:8818023 |
| Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: norethisterone oenanthate and medroxyprogesterone acetate. 1. Use-effectiveness. | 1977 | Contraception | pmid:880823 | |
| Hillier SG et al. | Long-term contraception by steroid releasing implants. VI. Serum concentrations of norethindrone in women bearing a single silastic implant releasing norethindrone acetate. | 1977 | Contraception | pmid:880821 |
| Kulkarni BD et al. | Steroid contraceptives in non-human primates (II). Metabolic fate of synthetic estrogens in the baboon after exposure to oral contraceptives. | 1977 | Contraception | pmid:880810 |
| Jeyaseelan S et al. | Local tissue response to silastic implant containing norethindrone acetate in women. | 1977 | Contraception | pmid:880802 |
| Back DJ et al. | The pharmacokinetics of norethisterone in the rabbit and rat after systemic and oral administration: effect of phenobarbitone [proceedings]. | 1977 | Br. J. Pharmacol. | pmid:880448 |
| Marchesoni D et al. | Transdermal estroprogestins versus transdermal estrogen plus oral dihydrogesterone replacement in menopause. | 1996 | J. Endocrinol. Invest. | pmid:8796334 |
| Evans SF and Davie M | Added effect of progestogens on bone mineral density response to oestrogen. | 1996 | Clin. Endocrinol. (Oxf) | pmid:8796150 |